{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T23:20:03Z","timestamp":1794871203622,"version":"4.9.1"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anaerobe"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.anaerobe.2026.103085","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:01:40Z","timestamp":1790175700000},"page":"103085","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Bifidobacteria and Clostridioides difficile infection: review of emerging therapeutic perspectives"],"prefix":"10.1016","volume":"100","author":[{"given":"Laura","family":"Obry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1020-4990","authenticated-orcid":false,"given":"Ana\u00efs","family":"Brosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anaerobe.2026.103085_bib1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-micro-090816-093458","article-title":"Clostridium difficile toxin biology","volume":"71","author":"Aktories","year":"2017","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.anaerobe.2026.103085_bib2","first-page":"723","article-title":"The role of toxins in Clostridium difficile infection","volume":"41","author":"Chandrasekaran","year":"2017","journal-title":"FEMS (Fed. Eur. Microbiol. Soc.) Microbiol. Rev."},{"key":"10.1016\/j.anaerobe.2026.103085_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jhin.2022.05.011","article-title":"One-day prevalence of asymptomatic carriage of toxigenic and non-toxigenic Clostridioides difficile in 10 French hospitals","volume":"129","author":"Le Monnier","year":"2022","journal-title":"J. Hosp. Infect."},{"key":"10.1016\/j.anaerobe.2026.103085_bib4","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.cmi.2021.09.038","article-title":"European society of clinical microbiology and infectious diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults","volume":"27","author":"Prehn","year":"2021","journal-title":"Clin. Microbiol. Infection"},{"key":"10.1016\/j.anaerobe.2026.103085_bib5","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s40265-022-01797-x","article-title":"Efficacy and safety of RBX2660 in PUNCH CD3, a phase III, randomized, double-blind, placebo-controlled trial with a bayesian primary analysis for the prevention of recurrent Clostridioides difficile infection","volume":"82","author":"Khanna","year":"2022","journal-title":"Drugs"},{"key":"10.1016\/j.anaerobe.2026.103085_bib6","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa2106516","article-title":"SER-109, an oral microbiome therapy for recurrent Clostridioides difficile infection","volume":"386","author":"Feuerstadt","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.anaerobe.2026.103085_bib7","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1001\/jama.2023.4314","article-title":"VE303, a defined bacterial consortium, for prevention of recurrent Clostridioides difficile infection: a randomized clinical trial","volume":"329","author":"Louie","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.anaerobe.2026.103085_bib8","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2337312","article-title":"New treatment approaches for Clostridioides difficile infections: alternatives to antibiotics and fecal microbiota transplantation","volume":"16","author":"Bratkovi\u010d","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.anaerobe.2026.103085_bib9","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2147\/IDR.S419243","article-title":"Microbiota-based live biotherapeutic products for Clostridioides difficile Infection- the devil is in the details","volume":"17","author":"Monday","year":"2024","journal-title":"IDR"},{"key":"10.1016\/j.anaerobe.2026.103085_bib10","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1038\/s41467-021-22302-0","article-title":"Microbiota-based markers predictive of development of Clostridioides difficile infection","volume":"12","author":"Berkell","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.anaerobe.2026.103085_bib11","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3390\/pathogens11070781","article-title":"Gut microbiota composition associated with Clostridioides difficile colonization and infection","volume":"11","author":"Martinez","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.anaerobe.2026.103085_bib12","doi-asserted-by":"crossref","first-page":"5.3.21","DOI":"10.1128\/microbiolspec.BAD-0010-2016","article-title":"Bifidobacteria and their health-promoting effects","volume":"5","author":"Hidalgo-Cantabrana","year":"2017","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.anaerobe.2026.103085_bib65","doi-asserted-by":"crossref","first-page":"D748","DOI":"10.1093\/nar\/gkae959","article-title":"BacDive in 2025: the core database for prokaryotic strain data","volume":"53","author":"Schober","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.anaerobe.2026.103085_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2016.00577","article-title":"Screening of bifidobacteria and lactobacilli able to antagonize the cytotoxic effect of Clostridium difficile upon intestinal epithelial HT29 monolayer","volume":"7","author":"Vald\u00e9s-Varela","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.anaerobe.2026.103085_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1293149","article-title":"Unveiling the inhibition mechanism of Clostridioides difficile by Bifidobacterium longum via multiomics approach","volume":"14","author":"Jo","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.anaerobe.2026.103085_bib26","doi-asserted-by":"crossref","first-page":"448","DOI":"10.3390\/nu11020448","article-title":"In vitro antimicrobial activity and probiotic potential of bifidobacterium and lactobacillus against species of clostridium","volume":"11","author":"Monteiro","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.anaerobe.2026.103085_bib16","doi-asserted-by":"crossref","DOI":"10.1128\/msystems.00620-19","article-title":"Identification of Clostridioides difficile-inhibiting gut commensals using culturomics, phenotyping, and combinatorial community assembly","volume":"5","author":"Ghimire","year":"2020","journal-title":"mSystems"},{"key":"10.1016\/j.anaerobe.2026.103085_bib20","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.anaerobe.2012.08.005","article-title":"Prebiotic-non-digestible oligosaccharides preference of probiotic bifidobacteria and antimicrobial activity against Clostridium difficile","volume":"18","author":"Kondepudi","year":"2012","journal-title":"Anaerobe"},{"key":"10.1016\/j.anaerobe.2026.103085_bib22","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3389\/fmicb.2018.00888","article-title":"Protective effects of bifidobacterial strains against toxigenic Clostridium difficile","volume":"9","author":"Wei","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.anaerobe.2026.103085_bib38","article-title":"Lactococcus lactis and Bifidobacterium longum attenuate Clostridioides difficile- or Clostridium symbiosum-induced colitis and depression\/anxiety-like behavior in male mice","volume":"27","author":"Joo","year":"2025","journal-title":"Microb. Infect."},{"key":"10.1016\/j.anaerobe.2026.103085_bib13","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0924-8579(02)00389-8","article-title":"Identification and screening for antimicrobial activity against Clostridium difficile of Bifidobacterium and Lactobacillus species isolated from healthy infant faeces","volume":"21","author":"Lee","year":"2003","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.anaerobe.2026.103085_bib17","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2021.1973835","article-title":"Next-generation prebiotic promotes selective growth of bifidobacteria, suppressing Clostridioides difficile","volume":"13","author":"Hirano","year":"2021","journal-title":"Gut Microbes"},{"key":"10.1016\/j.anaerobe.2026.103085_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2024.107250","article-title":"Bifidobacteria antagonize the life cycle of Clostridioides difficile","volume":"199","author":"Soldavini Pelichotti","year":"2025","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.anaerobe.2026.103085_bib21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijpharm.2016.12.005","article-title":"In vitro inhibition of Clostridium difficile by commercial probiotics: a microcalorimetric study","volume":"517","author":"Fredua-Agyeman","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.anaerobe.2026.103085_bib23","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.3389\/fmicb.2018.02953","article-title":"Effect of Bifidobacterium breve in combination with different antibiotics on Clostridium difficile","volume":"9","author":"Yang","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.anaerobe.2026.103085_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2019.00288","article-title":"Antibacterial activity of Bifidobacterium breve against Clostridioides difficile","volume":"9","author":"Yang","year":"2019","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.anaerobe.2026.103085_bib25","doi-asserted-by":"crossref","first-page":"6181","DOI":"10.1007\/s00253-022-12124-5","article-title":"Antagonistic activity of selenium-enriched Bifidobacterium breve against Clostridioides difficile","volume":"106","author":"Rui","year":"2022","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.anaerobe.2026.103085_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/ismejo\/wraf086","article-title":"Bifidobacterium breve synergizes with Akkermansia muciniphila and Bacteroides ovatus to antagonize Clostridioides difficile","volume":"19","author":"Li","year":"2025","journal-title":"ISME J."},{"key":"10.1016\/j.anaerobe.2026.103085_bib18","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.anaerobe.2006.03.004","article-title":"Inhibition of Clostridium difficile growth and adhesion to enterocytes by Bifidobacterium supernatants","volume":"12","author":"Trejo","year":"2006","journal-title":"Anaerobe"},{"key":"10.1016\/j.anaerobe.2026.103085_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2016.00738","article-title":"Effect of bifidobacterium upon Clostridium difficile growth and toxicity when co-cultured in different prebiotic substrates","volume":"7","author":"Vald\u00e9s-Varela","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.anaerobe.2026.103085_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10482-010-9424-6","article-title":"Co-culture with potentially probiotic microorganisms antagonises virulence factors of Clostridium difficile in vitro","volume":"98","author":"Trejo","year":"2010","journal-title":"Antonie Leeuwenhoek"},{"key":"10.1016\/j.anaerobe.2026.103085_bib27","doi-asserted-by":"crossref","first-page":"368","DOI":"10.5851\/kosfa.2017.37.3.368","article-title":"Beneficial effect of Bifidobacterium longum ATCC 15707 on survival rate of Clostridium difficile infection in mice","volume":"37","author":"Yun","year":"2017","journal-title":"Korean J Food Sci Anim Resour"},{"key":"10.1016\/j.anaerobe.2026.103085_bib33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1017\/S0022029913000216","article-title":"Protective effect of bifidobacteria in an experimental model of Clostridium difficile associated colitis","volume":"80","author":"Trejo","year":"2013","journal-title":"J. Dairy Res."},{"key":"10.1016\/j.anaerobe.2026.103085_bib35","doi-asserted-by":"crossref","first-page":"9243","DOI":"10.1007\/s00253-021-11668-2","article-title":"Evaluation of the therapeutic effect and dose\u2013effect of Bifidobacterium breve on the primary Clostridioides difficile infected mice","volume":"105","author":"Yang","year":"2021","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.anaerobe.2026.103085_bib37","article-title":"Probiotics ameliorate histological alterations and prevent increases in cytokine and toxin levels in mice infected with various Clostridioides difficile strains","author":"Hamo","year":"2025","journal-title":"Probiotics Antimicrob. Proteins"},{"key":"10.1016\/j.anaerobe.2026.103085_bib31","article-title":"Probiotics for the prevention of Clostridioides difficile\u2010associated diarrhea in adults and children","volume":"2025","author":"Esmaeilinezhad","year":"2025","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.anaerobe.2026.103085_bib32","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1128\/aem.49.1.250-252.1985","article-title":"Modulation of cytotoxin production by Clostridium difficile in the intestinal tracts of gnotobiotic mice inoculated with various human intestinal bacteria","volume":"49","author":"Corthier","year":"1985","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.anaerobe.2026.103085_bib34","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001857","article-title":"The state of play of rodent models for the study of Clostridioides difficile infection","volume":"73","author":"Brosse","year":"2024","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.anaerobe.2026.103085_bib36","article-title":"Therapeutic effects of Bifidobacterium breve YH68 in combination with vancomycin and metronidazole in a primary Clostridioides difficile-infected mouse model","volume":"10","author":"Yang","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.anaerobe.2026.103085_bib39","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0140-6736(13)61218-0","article-title":"Lactobacilli and bifidobacteria in the prevention of antibiotic-associated diarrhoea and Clostridium difficile diarrhoea in older inpatients (PLACIDE): a randomised, double-blind, placebo-controlled, multicentre trial","volume":"382","author":"Allen","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.anaerobe.2026.103085_bib40","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1093\/jac\/dkx254","article-title":"A randomized controlled trial of probiotics for Clostridium difficile infection in adults (PICO)","volume":"72","author":"Barker","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.anaerobe.2026.103085_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0204253","article-title":"Oral probiotic combination of Lactobacillus and Bifidobacterium alters the gastrointestinal microbiota during antibiotic treatment for Clostridium difficile infection","volume":"13","author":"Wolfe","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.anaerobe.2026.103085_bib42","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.chom.2018.11.002","article-title":"Microbiota-derived lactate accelerates intestinal stem-cell-mediated epithelial development","volume":"24","author":"Lee","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.anaerobe.2026.103085_bib43","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.imbio.2015.06.004","article-title":"Lactate and short chain fatty acids produced by microbial fermentation downregulate proinflammatory responses in intestinal epithelial cells and myeloid cells","volume":"220","author":"Iraporda","year":"2015","journal-title":"Immunobiology"},{"key":"10.1016\/j.anaerobe.2026.103085_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163694","article-title":"Lactate inhibits the pro-inflammatory response and metabolic reprogramming in murine macrophages in a GPR81-Independent manner","volume":"11","author":"Errea","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.anaerobe.2026.103085_bib45","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.tim.2017.10.001","article-title":"Glycan utilization and cross-feeding activities by bifidobacteria","volume":"26","author":"Turroni","year":"2018","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.anaerobe.2026.103085_bib46","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/gut.36.1.93","article-title":"Colonic mucin synthesis is increased by sodium butyrate","volume":"36","author":"Finnie","year":"1995","journal-title":"Gut"},{"key":"10.1016\/j.anaerobe.2026.103085_bib47","doi-asserted-by":"crossref","DOI":"10.4161\/gmic.21757","article-title":"Lactic acid production by Streptococcus thermophilus alters Clostridium difficile infection and in vitro toxin A production","author":"Kolling","year":"2012","journal-title":"Gut Microbes"},{"key":"10.1016\/j.anaerobe.2026.103085_bib48","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.anaerobe.2017.03.004","article-title":"Inhibition of spore germination, growth, and toxin activity of clinically relevant C. difficile strains by gut microbiota derived secondary bile acids","volume":"45","author":"Thanissery","year":"2017","journal-title":"Anaerobe"},{"key":"10.1016\/j.anaerobe.2026.103085_bib49","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nature13828","article-title":"Precision microbiome restoration of bile acid-mediated resistance to Clostridium difficile","volume":"517","author":"Buffie","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.anaerobe.2026.103085_bib50","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3389\/fcimb.2016.00191","article-title":"Functional intestinal bile acid 7\u03b1-Dehydroxylation by Clostridium scindens associated with protection from Clostridium difficile infection in a gnotobiotic mouse model","volume":"6","author":"Studer","year":"2016","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.anaerobe.2026.103085_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114379","article-title":"A new insight into the physiological role of bile salt hydrolase among intestinal bacteria from the genus Bifidobacterium","volume":"9","author":"Jarocki","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.anaerobe.2026.103085_bib52","doi-asserted-by":"crossref","first-page":"5603","DOI":"10.1128\/AEM.70.9.5603-5612.2004","article-title":"Cloning and characterization of the bile salt hydrolase genes (bsh) from Bifidobacterium bifidum strains","volume":"70","author":"Kim","year":"2004","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.anaerobe.2026.103085_bib53","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1128\/JB.00473-13","article-title":"The agr locus regulates virulence and colonization genes in Clostridium difficile 027","volume":"195","author":"Martin","year":"2013","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.anaerobe.2026.103085_bib54","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01237-16","article-title":"Accessory gene Regulator-1 Locus is essential for virulence and pathogenesis of Clostridium difficile","volume":"7","author":"Darkoh","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.anaerobe.2026.103085_bib55","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03190-20","article-title":"Combined and distinct roles of Agr proteins in Clostridioides difficile 630 sporulation, motility, and toxin production","volume":"11","author":"Ahmed","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.anaerobe.2026.103085_bib56","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1128\/JB.01980-12","article-title":"Multiple factors modulate biofilm Formation by the anaerobic pathogen Clostridium difficile","volume":"195","author":"\u00d0apa","year":"2013","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.anaerobe.2026.103085_bib57","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.3168\/jds.2014-7921","article-title":"Lactobacillus acidophilus modulates the virulence of Clostridium difficile","volume":"97","author":"Yun","year":"2014","journal-title":"J. Dairy Sci."},{"key":"10.1016\/j.anaerobe.2026.103085_bib58","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/lam.13124","article-title":"Suppressive effect of Lactobacillus fermentum Lim2 on Clostridioides difficile 027 toxin production","volume":"68","author":"Yong","year":"2019","journal-title":"Lett. Appl. Microbiol."},{"key":"10.1016\/j.anaerobe.2026.103085_bib59","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.anaerobe.2012.08.006","article-title":"Bifidobacterium spp. influences the production of autoinducer-2 and biofilm formation by Escherichia coli O157:H7","volume":"18","author":"Kim","year":"2012","journal-title":"Anaerobe"},{"key":"10.1016\/j.anaerobe.2026.103085_bib60","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aat6975","article-title":"Cell surface polysaccharides of Bifidobacterium bifidum induce the generation of Foxp3+ regulatory T cells","volume":"3","author":"Verma","year":"2018","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.anaerobe.2026.103085_bib61","doi-asserted-by":"crossref","first-page":"518","DOI":"10.4014\/jmb.1205.05018","article-title":"Effect of probiotics lactobacillus and bifidobacterium on gut-derived lipopolysaccharides and inflammatory cytokines: an In vitro Study using a human colonic microbiota model","volume":"23","author":"Rodes","year":"2013","journal-title":"J. Microbiol. Biotechnol"},{"key":"10.1016\/j.anaerobe.2026.103085_bib62","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1348-0421.2011.00398.x","article-title":"Anti-inflammatory properties of intestinal Bifidobacterium strains isolated from healthy infants","volume":"56","author":"Khokhlova","year":"2012","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.anaerobe.2026.103085_bib63","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.4014\/jmb.1805.05072","article-title":"Effects of orally-administered Bifidobacterium animalis subsp. lactis strain BB12 on dextran sodium sulfate-induced colitis in mice","volume":"28","author":"Chae","year":"2018","journal-title":"Food Microbiol. Biotechnol (FMB)"},{"key":"10.1016\/j.anaerobe.2026.103085_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.123017","article-title":"Exopolysaccharides from Bifidobacterium longum subsp. infantis and Bifidobacterium adolescentis modulate toll-like receptor signaling","volume":"349","author":"Akkerman","year":"2025","journal-title":"Carbohydr. Polym."}],"container-title":["Anaerobe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107599642600065X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107599642600065X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T23:12:14Z","timestamp":1794870734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107599642600065X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":65,"alternative-id":["S107599642600065X"],"URL":"https:\/\/doi.org\/10.1016\/j.anaerobe.2026.103085","relation":{},"ISSN":["1075-9964"],"issn-type":[{"value":"1075-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bifidobacteria and Clostridioides difficile infection: review of emerging therapeutic perspectives","name":"articletitle","label":"Article Title"},{"value":"Anaerobe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anaerobe.2026.103085","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103085"}}